Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARE preschool asthma reliever trial
ACTRN12623000670673Phase 3Recruiting
- Sponsor
- The University of Auckland
- Start
- Jul 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of budesonide, formoterol and salbutamol in asthma and recurrent wheeze (2 arms), sponsored by The University of Auckland. Primary endpoint: Moderate and severe asthma/wheeze exacerbations. Started Jul 2023; status: recruiting.
02
Drugs
budesonideformoterolsalbutamol
03
Conditions
asthmarecurrent wheeze
Beyond the preview
Go deeper on ACTRN12623000670673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000670673.